Virbac UK Veterinary
Caution, This content is for veterinary professionals.


Part of a streamlined range of vaccines with a straightforward protocol to provide excellent protection against core feline diseases

Leucogen® is the World’s first recombinant subunit vaccine containing purified p45 FeLV-envelope antigen identified as the most important antigen for stimulating immunity to FeLV.

Product Features & Benefits: 

  • Provides targeted effective antigenic challenge 

  • 3 year duration of immunity

  • Proven efficacy and safety2,3

  • Recombinant subunit FeLV vaccine

  • Protects against all 3 subgroups of FeLV


Presentations Available: 

Available in 10 or 50 doses.


1. Summary of Product Characteristics. 
2. Jarrett O et al. Comparative studies of the efficacy of a recombinant feline leukaemia, The Veterinary Record 1996; 138:7-11. 
3. Lutz H. Comparative studies of the effi cacy of two leukaemia virus vaccines. Proceedings of the 4th European FECAVA Congress 1998.

Caution, This content is for veterinary professionals. Login to access the content.